Free Trial

Covid Vaccine Talk Helps AUD/USD Reclaim $0.7200

FOREX

USD weakness has carried over into the Asia-Pac session and the greenback lags all of its G10 peers, with DXY trading through Thursday's low. The move seems to have been sparked by existing impetus, but some additional pressure to the greenback may have come from mildly risk-positive BBG headlines noting that Pfizer's Covid-19 vaccine is on track to receive regulatory review as soon as in Oct. AUD gained some steam on the news, with AUD/USD rising past $0.7200.

  • AUD/NZD keeps pushing higher, but is yet to attack yesterday's best levels. NZD has ground lower from the off, as RBNZ policymakers stuck to their familiar talking points, with Chief Economist Ha pointing to international evidence that negative interest rates work.
  • Preliminary PMI data from across the world, U.S existing home sales, UK & Canadian retail sales and EZ consumer confidence take focus today.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.